~~<i id='FBC0336C06'><strike id='FBC0336C06'><tt id='FBC0336C06'><pre id='FBC0336C06'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：explore 2025-09-06 04:26:49 - browse：8542

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Medicare drug price negotiation hearing pits pharma v Biden admin

leisure time

focus

leisure time

focus

AdobeArtificialintelligencehastheabilitytorevolutionizehumanhealth.Itisusedtodetect potentiallycance

WSS

He's 19 months old and has one of the world’s rarest diseases

Stem cell biologist probes earliest stages of human development

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Fetal cell organoids grown from amniotic fluid, study finds

What the Wegovy shortage looks like for doctors — and for patients

Why Talkspace is targeting Medicare, a tricky market

knowledge

focus

Featured Speakers

leisure time

Peter Hotez and the public health issue of online harassment

How clinical AI models' predictive power can degrade over time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Massive project maps cells in human brain in unprecedented detail

Alkermes shareholders re

Ozempic has benefits for kidney disease as well as diabetes

BioMarin wins approval for gene therapy to treat hemophilia A

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

BioMarin wins approval for gene therapy to treat hemophilia A

How doctors and nurses shape Google's AI

leisure time

Microsoft's Peter Lee: Generative AI could help doctors be more human

IVF doctors demand details after CooperSurgical lawsuit

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Lack of health data on LGBTQ+ people has serious consequences

How should state employee insurance handle Wegovy?

Florida health officials providing scant details on measles cases

focus

focus

leisure time

focus